Wakefield, MA, United States of America

Thomas Allen Miller

USPTO Granted Patents = 54 


 

Average Co-Inventor Count = 4.3

ph-index = 13

Forward Citations = 401(Granted Patents)

DiyaCoin DiyaCoin 0.42 


Inventors with similar research interests:


Location History:

  • Hastings, FL (US) (1984)
  • Charlottesville, VA (US) (1996)
  • New York, NY (US) (2003 - 2012)
  • Brookline, MA (US) (2007 - 2014)
  • Wakefield, MA (US) (2013 - 2023)
  • Lexington, MA (US) (2023)

Company Filing History:


Years Active: 1984-2025

where 'Filed Patents' based on already Granted Patents

54 patents (USPTO):

Title: **Innovative Contributions of Thomas Allen Miller**

Introduction

Thomas Allen Miller, based in Wakefield, MA, is an accomplished inventor with an impressive portfolio of 53 patents to his name. His work primarily focuses on the fields of biochemistry and pharmacology, contributing significantly to advancements in enzyme purification and anti-fibrotic therapies.

Latest Patents

Among his latest contributions, Miller holds a patent for the "Affinity purification of glycosidase-cleaving enzymes." This invention details an affinity resin that is functionalized with small molecule inhibitors of glycoside-cleaving enzymes such as α-galactosidase A and glucocerebrosidase. The method he developed allows for the purification of these enzymes produced in various cell lines, enhancing the efficacy of biochemical research and therapeutic applications.

Another significant patent by Miller is for "Anti-fibrotic compounds." This invention presents compounds that inhibit the TGF-beta signaling pathway, providing potential therapies for diseases associated with fibrosis, inflammation, and neoplastic conditions. Along with these compounds, pharmaceutical compositions are also included, reflecting his innovative approach to drug development.

Career Highlights

Miller's professional journey includes valuable experience at prominent pharmaceutical companies like Merck Sharp & Dohme Corporation and Merck Hdac Research, LLC. His work in these organizations has been instrumental in advancing research and development in the biotech field, particularly in enzyme functionality and treatment methodologies.

Collaborations

Throughout his career, Miller has collaborated with notable colleagues including David James Witter and Victoria M Richon. These partnerships have helped foster innovation and the sharing of ideas, which are crucial in pushing the boundaries of medical science.

Conclusion

Thomas Allen Miller exemplifies the spirit of innovation in the life sciences sector. With his extensive patent portfolio and collaborative efforts, he continues to contribute to significant advancements in enzyme purification and anti-fibrotic therapies, making a remarkable impact in the field of biochemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…